High match accuracy is crucial because it can significantly improve treatment outcomes. When patients receive therapies that are well-suited to their specific type of cancer and genetic makeup, they are more likely to respond positively, experience fewer side effects, and have a better overall prognosis. This approach also helps to avoid the inefficiencies and costs associated with trial-and-error methods of treatment.
